These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9004919)

  • 1. A new approach to labeling cells with technetium-99m, Part I. Preparation of modified polylysine and in vitro cell labeling.
    Mahmood A; Delmon-Moingeon LI; Limpa-Amara N; Davison A; Jones AG
    Nucl Med Biol; 1996 Jan; 23(1):79-85. PubMed ID: 9004919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new approach to labeling cells with technetium-99m, Part II. Evaluation of radiolabeled human-lymphocyte immune functions.
    Delmon-Moingeon LI; Mahmood A; Davison A; Jones AG
    Nucl Med Biol; 1996 Jan; 23(1):87-95. PubMed ID: 9004920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro studies of leukocyte labeling with technetium-99m.
    Uchida T; Vincent PC
    J Nucl Med; 1976 Aug; 17(8):730-6. PubMed ID: 932819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m-white blood cell-specific imaging agent developed from platelet factor 4 to detect infection.
    Moyer BR; Vallabhajosula S; Lister-James J; Bush LR; Cyr JE; Snow DA; Bastidas D; Lipszyc H; Dean RT
    J Nucl Med; 1996 Apr; 37(4):673-9. PubMed ID: 8691265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical considerations in labeling of blood elements.
    Eckelman WC
    Semin Nucl Med; 1975 Jan; 5(1):3-10. PubMed ID: 1118736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc labeling white blood cells with a simple technique: clinical application.
    Gutfilen B; Pellini MP; de Roure e Neder J; de Amarante Júnior JL; Evangelista MG; Fernandes SR; Bernardo-Filho M
    Ann Nucl Med; 1994 Feb; 8(1):85-9. PubMed ID: 8204402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro and in vivo studies using 111 indium oxine, 111 indium oxine sulfate and 99m Tc oxine in erythrocyte labeling].
    Reiter S; Angelberger P; Kolbe H; Sinzinger H
    Wien Klin Wochenschr; 1984 Feb; 96(3):120-3. PubMed ID: 6426172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-pool imaging using technetium-99m-labeled liposomes.
    Goins B; Phillips WT; Klipper R
    J Nucl Med; 1996 Aug; 37(8):1374-9. PubMed ID: 8708778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m mercaptoalbumin as a potential substitute or technetium-99m labelled red blood cells.
    Verbeke KA; Vanbilloen HP; De Roo MJ; Verbruggen AM
    Eur J Nucl Med; 1993 Jun; 20(6):473-82. PubMed ID: 8339730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cyclosporine-A on labeling blood cells with radiopharmaceuticals.
    Owunwanne A; Shihab-Eldeen A
    Nucl Med Biol; 1996 Nov; 23(8):1019-21. PubMed ID: 9004292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of accumulation of 99mTc-sulesomab in inflammation.
    Skehan SJ; White JF; Evans JW; Parry-Jones DR; Solanki CK; Ballinger JR; Chilvers ER; Peters AM
    J Nucl Med; 2003 Jan; 44(1):11-8. PubMed ID: 12515870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labelling of leucocytes with technetium-99m exametazime causes in vitro upregulation of granulocyte CD11b without correlation to tissue uptake in vivo.
    Almer S; Ljunghusen O; Lundahl J
    Eur J Nucl Med; 1996 Jun; 23(6):669-74. PubMed ID: 8662101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of granulocyte labeling with [99mTc]d,1-HM-PAO.
    Mortelmans L; Malbrain S; Stuyck J; De Backker C; Heynen MJ; Boogaerts M; De Roo M; Verbruggen A
    J Nucl Med; 1989 Dec; 30(12):2022-8. PubMed ID: 2585105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of drugs on the labeling of blood elements with technetium-99m.
    Braga AC; Oliveira MB; Feliciano GD; Reiniger IW; Oliveira JF; Silva CR; Bernardo-Filho M
    Curr Pharm Des; 2000 Jul; 6(11):1179-91. PubMed ID: 10903389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m labeling of red blood cells: in vitro evaluation of a new approach.
    Kelbaek H
    J Nucl Med; 1986 Nov; 27(11):1770-3. PubMed ID: 3772511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
    Edwards DS; Liu S; Barrett JA; Harris AR; Looby RJ; Ziegler MC; Heminway SJ; Carroll TR
    Bioconjug Chem; 1997; 8(2):146-54. PubMed ID: 9095354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, 99mTc-labeling and biodistribution studies of a PNA oligomer containing a new ligand derivative of 2,2'-dipicolylamine.
    Gasser G; Jäger K; Zenker M; Bergmann R; Steinbach J; Stephan H; Metzler-Nolte N
    J Inorg Biochem; 2010 Nov; 104(11):1133-40. PubMed ID: 20674031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization and radiolabeling of a new amphiphilic derivative of DTPA.
    Aldenhoff YB; Van Kroonenburgh MJ; Koole LH
    Nucl Med Biol; 1996 Jul; 23(5):653-6. PubMed ID: 9044688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m-alendronate: a new radiopharmaceutical for bone scanning.
    Arteaga de Murphy C; Meléndez-Alafort L; Montoya-Molina C; Sepúlveda-Méndez J
    Arch Med Res; 1996; 27(4):481-3. PubMed ID: 8987181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
    Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
    Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.